Your session is about to expire
← Back to Search
CPC - Capsaicin, Phenylephrine, Caffeine for Vasovagal Syncope
Study Summary
This trial will test the effects of a new medication, CPC, on people with a history of fainting spells brought on by sudden changes in position.
- Vasovagal Syncope
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You cannot undergo tilt testing due to a medical condition.You cannot take your Midodrine or beta-blocker medication 48 hours before the tilt table test.You have a confirmed diagnosis of vasovagal syncope or near syncope.If the study investigators feel that any physical or psychological symptom would make you unsuitable for the study.You are taking medication(s) that the study team thinks would make you ineligible for the study. Examples include fludrocortisone, theophylline, prazosin, doxazosin, terazosin, MAO-inhibitors, pseudoephedrine, decongestant, and PDE5 inhibitors.You have a history of heart or brain problems.
- Group 1: CPC Adminstration
- Group 2: Placebo Adminstration
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What condition does the medication CPC - Capsaicin, Phenylephrine, Caffeine commonly help?
"The symptoms of eye pain and an enlarged pupil can both be alleviated by using a medication that contains capsaicin, phenylephrine, and caffeine."
Has the FDA cleared CPC - Capsaicin, Phenylephrine, Caffeine for use?
"CPC - Capsaicin, Phenylephrine, Caffeine - is currently in Phase 2 of clinical trials. While there is evidence that it is safe, more research needs to be done to support its efficacy."
Would this test be appropriate for somebody who is middle-aged?
"This particular clinical trial has an age range of 18 to 50 for patients who wish to enroll."
Are there any specific inclusion criteria for subjects of this research?
"This trial is looking for 132 participants who have syncope and are between 18-50 years old."
Is this research study still open to new participants?
"That is correct, the online information does show that the medical study is still recruiting individuals. The listing was first put up on July 20th, 2021 and was last updated 30 days ago. The researchers conducting the trial need 132 patients total, and are only looking at one potential site."
Share this study with friends
Copy Link
Messenger